ask="19.68"
ask_size="200"
average_daily_volume="146980"
bid="12.00"
bid_size="600"
book_value="6.55"
change="-0.24"
change_from_200_day_moving_average="2.40"
change_from_50_day_moving_average="1.62"
change_from_52_week_high="-1.24"
change_From_52_week_low="6.19"
change_in_percent="-1.30%"
close="18.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.01"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.06"
ex_dividend_date="N/A"
float_shares="11609000"
high="18.73"
high_52_weeks="19.50"
last_trade_date="3/1/2017"
last_trade_price="18.26"
last_trade_size="6796"
last_trade_time="4:00pm"
low="17.60"
low_52_weeks="12.07"
market_capitalization="401.39M"
moving_average_200_day="15.86"
moving_average_50_day="16.64"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.83"
open="18.73"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+15.11%"
percent_change_from_50_day_moving_average="+9.71%"
percent_change_from_52_week_high="-6.36%"
percent_change_from_52_week_low="+51.28%"
previous_close="18.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.82"
price_per_sales="384.01"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="19.33"
stock_exchange="NGM"
symbol="ADMS"
volume="234033"
weeks_range_52="12.07 - 19.50"
